Mr James Frith

Mr James Frith

Labour — Bury North

Speaking in the House of Commons on 16 November 2026

Debate

Health and Care: Digital Capability

Contribution

With permission, I would like to make a statement on digital capability for health and care. This Government are determined to give patients access to technology that supports their care while improving productivity. We want to give the health and care system more choice, greater resilience and less dependence on any single supplier, as well as the ability to adapt and evolve as new technologies emerge in future, with better value for taxpayers through time. These objectives require a new approach: one that will stimulate a more diverse and innovative supplier market, including greater use of sovereign AI as well as internationally developed capabilities, building on the shift from analogue to digital set out in the 10-year health plan. As we have just been learning, the global outage of certain Microsoft systems on Friday brought home the importance of avoiding overdependence. Our future capability should avoid being locked into any single technology. We need a new approach—one that will boost competition, demand interoperability and diversify NHS technology within a safe and modern regulatory framework. That approach has three parts: investing in strategic technologies; changing how future technology capabilities are procured; and developing open standards and our safety regime. In the Budget, my right hon. Friend the Chancellor confirmed a further £140 million for sovereign AI. The NHS will work with sovereign AI on speeding up clinical trials, monitoring medicines safety and scaling proven AI products across the NHS, such as cancer cell detection. The Government have committed to using public procurement as a strategic lever to back British industry and ensure communities benefit from growth and good jobs. We will evolve NHS procurement processes in line with that aim. Within a fair and open competition framework, we will use our purchasing power to create routes to market for innovative companies, giving British start-ups a fair crack at NHS contracts. Rather than the NHS simply buying the technology of the future, we want it to help create the market for it. That is where the federated data platform comes in. Fragmented information stops the NHS from providing patients with effective and emotionally intelligent care. A hospital can have beds available, but struggle to match them with patients waiting to be admitted. A clinical team can waste valuable time trying to understand where patients are on a waiting list, rather than treating them. Different parts of the NHS can hold pieces of the same operational jigsaw without being able to see the whole picture. Those are just some of the problems the FDP is helping the NHS to solve. Technology and Government priorities have moved on since the original FDP procurement in 2023 and our procurement model needs to move with them, so today I can update the House: we will begin a new procurement process along different lines from the current contract. From January, the NHS will begin this vital work with patients, our partners and the market. Formal procurement will begin in the second half of next year and we expect the full process, from engagement to completion, to take around 18 months. This is about the NHS building on what works, while opening the next generation of FDP to the best technologies. Interoperability, resilience and trusted common standards can and must be baked into the next generation of FDP. We will also start work, alongside the new procurement, to work with different providers on developing new capabilities and expertise starting with systems used in maternity care. Innovative providers will be invited to help address the data and digital fragmentation in this important area of care, and to test how health priorities can create routes to build UK AI capability. We will announce further details within the next few weeks. A process this important must command public trust as well as clinical confidence. Public trust is won through clear rules, transparency, independent scrutiny and a demonstrable control over who can access people’s information, for what purpose and under whose authority. That is why the design of future FDP capabilities and contractual arrangements will be informed by frontline NHS teams, patients and the public. Just as with the single patient record, we will seek views through our public deliberations programme, working with the National Data Guardian and a dedicated patient panel. The FDP is live in 142 NHS trusts and 35 integrated care boards and supports operational services including vaccine supply chains, theatre scheduling and discharge planning. Trusts and patients are benefiting from those services, and they must remain stable while the future model is designed and procured. While future arrangements are developed, and the new procurement process is completed, the current contract will remain for two years, before coming to an end. This decision is a bridge, not the destination. While we create the conditions for new technologies and suppliers to contribute tomorrow, we are protecting the capabilities the NHS relies on today. Throughout the period, trusts and ICBs can and should still make full use of the capabilities available on the FDP to improve their performance and productivity, including those yet to sign up or fulfil its potential for them. The contract will end in March 2029, when we intend to complete the transition to the new FDP with the additional capabilities. We will ensure the necessary controls and conditions are in place to do so without disrupting patient care. There are many advantages to having a diverse group of suppliers, but that diversity is only an asset if technologies can work together. Interoperability is vital for information to flow; common standards make that possible consistently; cyber-security protects it; and modern regulation ensures new technologies, including clinical AI, can be deployed safely and with confidence. Rather than letting innovation further fragment the NHS—letting it benefit this or that part of the system—we want to put a floor underneath innovation. Many colleagues, including those on Select Committees, have argued for the introduction of mandatory open data standards for the health and care system. I agree with those arguments. Today, I can confirm that this Government will introduce trusted common standards that enable information to flow consistently. At the same time, our safeguards and regulation must keep pace with rapidly developing AI, so we will continue to invest in the NHS’s cyber-security, and we have accepted each of the Medicines and Healthcare products Regulatory Agency’s 44 recommendations for AI regulation on cyber-security, interoperability, and transparency. We are now developing an implementation plan for that new regulatory approach, to be published next year. NHS organisations are already using the FDP to run and improve services for their patients. The approach I have set out today is about better outcomes for patients, giving staff the tools that they need to care, and making best use of resources for the taxpayer. It is a new approach to NHS technology, where we have a bridge to a new system that retains public confidence while promoting UK innovation—one based on competition going forward, continuity in the meantime, and NHS control throughout. I know colleagues will support those aims and I look forward to working with them as we put our approach into practice. I commend this statement to the House.

More from Mr James Frith

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

For Mr James Frith's full parliamentary record including voting history, expenses and all other contributions, see the Mr James Frith report card.